


Positive results from AELIX’ HIV therapeutic vaccine clinical study published in Nature Medicine

Enalees receives €500,000 subsidy

ABL and Imugene partner to advance oncolytic virus candidate towards later phase clinical trials

Bioxodes appoints Marc Dechamps as new CEO

L’écosystème de santé Belge montre une grande implication pour l’évènement européen HealthTech Innovation Days, les 13 à 14 octobre à Paris

Immunotherapy: Tollys presents new data at OTS 2022, demonstrating anti-tumor activity of TL-532

Covalab, CimCure and partners receive €1.06M EUREKA Eurostars grant to develop new combination therapy for glioblastoma

Tridek-One closes a €16 million financing round to develop first-in-class immune checkpoint agonists
